Qiming Star | Under Mayo Clinic Guidance, SinoUnited Health Launches Longevity Clinic, Pioneering Medical-Grade Longevity Management via Multidisciplinary Care and Digital Platform

"Longevity isn't just about 'living longer' — it's about 'living longer in good health.' If I had to define our Longevity Clinic in one sentence, it would be 'a medical-grade longevity program built to international standards,'" said Dr. Haoying Shi, founder and CEO of YourHealth Medical Group, president of Shanghai YourHealth Hospital, and director of cardiovascular medicine.

Recently, under the official guidance of Mayo Clinic, a globally renowned high-quality medical institution, Qiming Venture Partners portfolio company YourHealth Medical Group formally launched its Longevity Clinic in Shanghai.

Dr. Shi revealed that the clinic is rooted in nearly a decade of YourHealth's health management practice — serving tens of thousands of families through continuous physical examinations and interventions, standardized protocols and evidence-based data systems, and collaborative experience across its "general practice + specialty" multidisciplinary centers.

The Longevity Clinic took over a year to prepare. YourHealth Medical Group assembled multidisciplinary teams spanning cardiovascular medicine, endocrinology, neurology, sports medicine, nutrition, sleep medicine, psychology and general practice, and traditional Chinese medicine, combining molecular and proteomics analysis, biomarkers, advanced imaging, and digital platforms. By integrating the latest global evidence in lifestyle medicine, the group has fully brought Mayo Clinic's deeply evidence-based longevity medicine philosophy and advanced chronic disease and anti-aging management model to China.

01/

International Standards, Localized

Dr. Stacey Rizza, executive medical director for Mayo Clinic in the Asia-Pacific region, stated that YourHealth's Longevity Clinic strictly adheres to the world's first evidence-based and internationally recognized clinical guideline for longevity clinics — the Standards for a Health Longevity Medicine Clinic — while leveraging YourHealth's robust integrated capabilities in "disease-specific + chronic disease" management. "While introducing cutting-edge international medical knowledge and technology, we are building a longevity clinic system adapted to the Chinese population, providing scientific, systematic, personalized, and verifiable medical-grade longevity management solutions."

There are several notable aspects to YourHealth Medical Group, as a serious medical institution, opening a longevity clinic: first, deep multidisciplinary collaboration; second, benchmarking against and localizing international standards; third, applying digital technology and AI where it actually matters.

Professor Jinglei Wu, vice chairman of the Shanghai Association for Science and Technology and president of the Shanghai Medical Association, attended the clinic's opening ceremony.

02/

A Multidisciplinary Relay

Dr. Shi said: "International medicine, Chinese innovation — health knows no borders. Grounded in international medical standards, YourHealth brings together cutting-edge global technology and multidisciplinary excellence, using digital technology and AI as engines to truly make longevity medicine a multidisciplinary relay."

"Every specialty has its blind spots, but when we sit at the same table for the same patient, we fill in the gaps." YourHealth's multidisciplinary team integrates "specialty-specific answers" into a "holistic solution," making complex problems clear and actionable.

Not long ago, a patient engaged in long-term high-intensity lower limb training developed varicocele. The mechanism typically involves elevated intra-abdominal pressure obstructing pelvic and spermatic venous return, impairing venous valve function, and triggering varicose veins — which can further affect testicular function and testosterone levels, with cascading effects on physical performance, metabolism, and training outcomes.

A single-discipline perspective would struggle to identify the full chain of risks. YourHealth's sports medicine, urology/andrology, endocrinology, and cardiovascular specialists conducted a joint assessment, ultimately delivering a solution with clear causality, controllable risks, and a well-defined pathway.

Going forward, YourHealth Medical Group will leverage these core competitive advantages in longevity medicine, fully realizing the benefits of its general-practice-coordinated, multidisciplinary joint decision-making collaborative network.

Additionally, supported by evidence-based medicine, YourHealth will assist individuals interested in longevity management in translating six lifestyle factors with significant relevance to longevity into daily actionable plans: regular moderate-to-high-intensity physical activity, high-quality diet, avoiding smoking, reducing alcohol consumption, maintaining healthy body weight, and strong social connections (don't "drop out of the group" after retirement — stay present).

The ultimate goal is to combine these foundational interventions with dynamic reassessment and target management, making change "visible, sustainable, and effective over the long term."

03/

AI and Digital Platform Support

The challenge of multidisciplinary collaboration lies in fragmented information and communication costs. YourHealth Medical Group has introduced AI and digital platforms on both the physician and patient sides.

On the physician side, AI integrates medical histories, examinations, medications, and cross-disciplinary conclusions, flagging potential interactions, assisting joint decision-making, reducing "transmission loss," and improving collaboration efficiency and consistency.

On the patient side, AI aggregates individual data, goals, and preferences, providing readable, actionable, and trackable recommendations; it also delivers intelligent reminders for plan changes, abnormal trends, and follow-up milestones.

Throughout the entire longevity management process, the digital platform runs through every stage — assessment, planning, execution, follow-up, and reassessment — enabling both data accumulation and quality improvement, while providing infrastructure for acquiring and analyzing real-world data from wearable devices, home monitoring, genetic and molecular diagnostics, and new treatment methods.

YourHealth Medical Group follows the principle of "embrace openly, implement cautiously" — safety first, then efficacy; validate first, then scale; steadily advancing the Longevity Clinic program within ethical and regulatory frameworks.

In fact, longevity medicine remains in rapid growth: patient interest is high, translating research into practice remains challenging, and unified standards at the clinic level are still being established; thus, collaborative efforts to build clinical standards and research databases are all the more necessary.

Going forward, YourHealth Medical Group will work with domestic and international academic and clinical institutions to advance standardization and conduct joint research, helping longevity medicine become a core component of preventive and personalized medicine.

---

PAST HIGHLIGHTS

Qiming Stars | YourHealth's Haoying Shi: Everything for High-Quality Medical Care Qiming Headlines | Qiming Venture Partners and Portfolio Companies Win Multiple Awards Including ChinaVenture 2024 Top 5 Best VC Firms Qiming Honors | Qiming Venture Partners Ranks 5th in Zero2IPO 2024 China VC Rankings, Among Five Awards

Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since inception, the firm has focused on investing in early and growth-stage outstanding enterprises in Technology and Healthcare.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. More than 80 portfolio companies have become recognized unicorns or super-unicorns.

Many Qiming Venture Partners portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), SinoCellTech (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.